NSW Cancer Summit

The inaugural NSW Cancer Summit 2025 was held at the ICC Sydney on 13 and 14 August 2025 and united leading minds to help shape the future of cancer prevention, treatment and care.

From cutting-edge laboratory research and groundbreaking innovations to prevention strategies, treatment advancements and holistic care approaches, the Summit spotlighted NSW’s world-leading efforts to support people impacted by cancer.

NSW Cancer Summit 2025 Day 1 Gallery

NSW Cancer Summit 2025 Day 2 Gallery

When and where?

When: Wednesday 13 and Thursday 14 August, 2025

Where: ICC Sydney

Time	Day 1
8.00am	Registration
8.45am	Session 1: Opening ceremony and plenary
	Equity, innovation and personalised care Chair: Professor Tracey O'Brien AM Room: Plenary Cockle Bay Room
8.45am	Cultural ceremony and Welcome to Country Metropolitan Local Aboriginal Land Council
9.10am	Opening address Professor Tracey O’Brien AM NSW Chief Cancer Officer and Chief Executive Officer, Cancer Institute NSW
9.25am	Plenary presentation Professor Jeff Dunn AO Chief of Mission and Head of Research, Prostate Cancer Foundation of Australia Chair of Cancer Survivorship and Professor of Social and Behavioural Science, University of Southern Queensland A war, moonshots and three beautiful words: Rambling reflections on contemporary cancer control
9.50am	Plenary presentation Mr Mike Lovas Director, Design and Innovation Cancer Digital Intelligence Princess Margaret Cancer Centre, UHN, Canada Beyond the hospital - designing cancer care that meets people where they are
10.15am	Welcome address The Hon. Ryan Park MP Minister for Health Minister for Regional Health and Minister for the Illawarra
10.30am	Morning tea Poster viewing
11.00am	Session 2: Day 1 morning concurrent
	Room: Plenary Cockle Bay Room Big data and AI transforming cancer care Chair: Professor Claire Vajdic, Kirby Institute UNSW Co-chair: Dr Lisa McCallum Cancer Institute NSW	Room: C3.3 Achieving equitable cancer outcomes Chair: Ms Nicole Turner AH&MRC of NSW Co-chair: Dr Ru Kwedza Cancer Institute NSW	Room: C3.4/C3.5 Precision medicine and the 'omics Chair: Professor Lisa Horvath Chris O'Brien Lifehouse	Room: C3.6 Effective prevention strategies: Complexities of keeping people healthy and well Chair: Ms Anita Dessaix Cancer Council NSW Co-chair: Professor Megan Varlow Cancer Institute NSW
11.00am	Professor Claire Vajdic Kirby Institute University of New South Wales Cancer incidence in women after medically assisted reproduction: A population-based cohort study	Mr Rami Rahal and Mr Te Miri Rangi Te Aho o Te Kahu New Zealand Weaving equity throughout cancer control in Aotearoa New Zealand	Professor David Thomas University of New South Wales Precision oncology, real world data and synthetic controls	Professor Becky Freeman University of Sydney Fighting industry interference to advance tobacco and vape use prevention
11.15am	Mr Matthew Warner-Smith Manager, Business Intelligence and Information Systems, Cancer Institute NSW Validation, implementation, and evaluation of artificial intelligence for radiology reporting in BreastScreen NSW	Ms Wendy Hoey PSM Justice Health NSW Achieving better cancer health outcomes for vulnerable communities	Professor Michelle Haber AM Children’s Cancer Institute ZERO Childhood Cancer: The power, opportunities and challenges of child cancer precision medicine	Associate Professor Michelle Kennedy University of Newcastle Indigenous-led evidence for effective prevention programs
11.30am	Professor Natasha Nassar University of Sydney Investigating impact of treatment on late effects of childhood cancer survivors using data linkage	Dr Bronwyn Newman Macquarie University Co-producing accessible patient reported measures with and for people with intellectual disability to improve equity in healthcare: the Listen to Me Project	Professor Susan Clark Garvan Institute of Medical Research	Professor Luke Wolfenden University of Newcastle Evolution of government efforts to prevent child obesity – reflections and future
11.45am	Dr Lisa McCallum Cancer Institute NSW Advancing cancer research: Leveraging CanDLe and our cancer data ecosystem for impact	Associate Professor Shalini Vinod South Western Sydney Local Health District A clinical quality dashboard to measure and address variation in lung cancer care	Professor Lisa Horvath Chris O’Brien Lifehouse Precision metabolic therapy in advanced prostate cancer	Professor Tina Skinner University of New South Wales An individualised exercise intervention improves outcomes for people with multiple myeloma
12.00pm	Associate Professor Julia Steinberg The Daffodil Centre Disparities in cancer survival by socioeconomic status in NSW, 1980–2019: Findings from a population-based study	Dr Suzanne Grant Western Sydney University Increasing CALD recruitment in cancer clinical trials by engaging interpreters and clinical trial staff	Associate Professor Emmy Fleuren Children's Cancer Institute Bench to bedside: How a molecular discovery influenced clinical drug recommendations for young sarcoma patients	Ms Irina Tupanceski Cancer Institute NSW NSW Skin Cancer Prevention Strategy 2023-2030: Development of the third statewide skin cancer prevention strategy
12.10pm	Dr Nicholas Hindley University of Sydney Maximising access while minimising toxicity: Real-time AI-guided radiation therapy	Ms Tameeka Ieremia Canteen Australia Co-designing Canteen's Aboriginal and Torres Strait Islander Culturally Responsive Framework	Mrs Amanda Woods GenesisCare Integrating precision medicine into clinical practice: Enhancing patient-centred care in radiation therapy	Dr Sandra Rickards Cancer Institute NSW Demonstrating effectiveness of anti-tobacco campaigns in NSW
12.20pm	Dr Joanna Fardell University of New South Wales National survey of clinical and research use of PROMs in paediatric oncology	Professor Simone Strasser Sydney Local Health District Innovations in wrap around care – Australia’s first support line for people with liver cancer	Dr Hani Kim Garvan Institute of Medical Research Building the human breast cancer atlas	Associate Professor Therese McGee Westmead Hospital Barriers to patient self-collected cervical screening in pregnancy
12.30pm	Lunch Poster viewing
1.30pm	Session 3: Day 1 afternoon concurrent
	Room: Plenary Cockle Bay Room In science we trust: Advances in cancer research Chair: Professor Anna DeFazio AM Westmead Institute for Medical Research University of Sydney Co-chair: Dr Dannel Yeo Centenary Institute of Cancer Medicine and Cell Biology	Room: C3.3 Living well with and beyond cancer Chair: Associate Professor Judith Lacey Chris O’Brien Lifehouse Co-Chair: Emma Wong University of Western Sydney	Room: C3.4/C3.5 Insights into patients' experiences: Patient Reported Measures Chairs: Mr Anthony Arnold Illawarra Shoalhaven Local Health District Dr Carolyn Mazariego University of New South Wales	Room: C3.6 Live from the clinic: Clinical innovations in cancer healthcare Chair: Associate Professor Abhijit Pal South West Sydney Local Health District Co-chair: Ms Maria Mury Cancer Institute NSW
1.30pm	Professor Helen Rizos Macquarie University Melanoma and immune checkpoint inhibitors: The tipping point between response and resistance	Ms Glenda Hill-Baulch Ovarian cancer survivor Living with cancer and beyond: The patient perspective Associate Professor Judith Lacey Chris O’Brien Lifehouse Keeping people well and thriving with and beyond cancer: An essential part of today’s comprehensive cancer care?	Mr Mike Lovas Princess Margaret Cancer Centre, UHN, Canada Reimagining patient reported outcome measures for personalised cancer care	Professor David Ma St Vincent's Hospital Sydney Virtual-delivered integrated healthcare intervention randomised control trial (RCT) for haematopoietic stem cell transplant (HCT) survivors Ms Nicole Knox University of Wollongong From Implementation to impact: Outcomes of a nurse-led geriatric oncology model of care (NL-GOMOC)
1.45pm	Professor Benjamin Kile Garvan Institute of Medical Research Emerging themes and new directions in cancer research	Dr David Mizrahi The Daffodil Centre Exercise is medicine for people with cancer	Ms Kim Williamson Cancer Institute NSW From patient voices to Action: Innovating care in NSW through Patient-Reported Measures	Associate Professor Daniel Steffens Surgical Outcomes Research Centre (SOuRCe) Consumer-driven evolution of prehabilitation models for gastrointestinal cancer patients in Australia
2.00pm	Associate Professor Kara Vine-Perrow University of Wollongong Smart delivery, safer therapies: Advancing implantable systems for pancreatic cancer treatment	Associate Professor Carolyn Ee Flinders University General practitioner’s role in cancer survivorship	Professor Bogda Koczwara AM University of New South Wales Realising the PROmise of personalised cancer care	Dr Jonathan Sykes Western Sydney Local Health District Head and neck cancer: Equitable referral for proton therapy
2.15pm	Professor Anna DeFazio AM Westmead Institute for Medical Research University of Sydney Decoding ovarian cancer to improve treatment: Are we there yet?		Dr Rebekah Laidsaar-Powell Psycho-oncology Co-operative Research Group, University of Sydney A distress screening and stepped care pathway for cancer carers: Development and initial reporting	Dr Jun Hee Hong Liverpool Hospital Prospective assessment of health-related quality of life in early phase clinical trials Associate Professor Lois Holloway South Western Sydney Local Health District An automated approach to contour quality assurance in the TROG 18.01 NINJA trial
2.30pm	Dr Shabarni Gupta Garvan Institute of Medical Research Cflows: Decoding tumour evolution through AI-driven discovery of temporal causal gene networks and cell-fate shifts	Dr Suzanne Grant Chris O'Brien Lifehouse Early supportive care program during neoadjuvant therapy (PROActiveB): Codesign and feasibility study	Dr Jennifer Cohen Canteen Listening to young voices: Using patient reported measures to understand adolescent and young adult experiences	Dr Rasha Cosman Garvan Institute of Medical Research PANNA-COTA (Practical Assessment of NECTA Network Assistance in Cancer Outpatient Trials Access) – Interim update
2.40pm	Dr Tahlia Scheinberg Chris O'Brien Lifehouse LEEP: A randomised, neoadjuvant trial of ribociclib prior to prostatectomy for high-risk localised prostate cancer	Miss Annaliese Alexakis University of New South Wales The gut microbiome and chemotherapy-associated neuropsychological outcomes in cancer patients: A systematic review	Dr Victoria Choi Chris O'Brien Lifehouse Real-world retrospective evaluation of EMR-integrated ePROMs in supportive and integrative oncology	Dr Paula Gonzalez-Figueroa Australian National University COSMOS-Avatar: Integrating therapeutic assessment in patient-derived xenografts and phase-I clinical trials for acute myeloid leukemia
2.50pm	Dr Debottam Sinha Frazer Institute, University of Queensland Breaking resistance: A novel treatment for N-MYC amplified high-risk neuroblastoma		Ms Catherine Johnson Calvary Mater Newcastle Implementing patient reported measures at point of care in a tertiary cancer clinic	Miss Zhicheng Li University of New South Wales "Nobody is born a smoker": A qualitative study of smoking cessation among high-risk individuals
3.00pm	Afternoon tea Poster viewing
3.30pm	Session 4: Plenary session
	Cancer control in Aboriginal communities Chair: Geraldine Wilson-Matenga Executive Director, Centre for Aboriginal Health NSW Ministry of Health Room: Plenary Cockle Bay Room
	Introducing - NSW Aboriginal Cancer Strategy 2025–2027 Professor Tracey O’Brien AM NSW Chief Cancer Officer and Chief Executive Officer Cancer Institute NSW Ms Nicole Turner Chief Executive Officer Aboriginal Health and Medical Research Council of NSW
	Implementing - NSW Aboriginal Cancer Strategy 2025–2027 Mr Anthony Carter Director, Aboriginal Strategy and Engagement Cancer Institute NSW Lesa Towers Executive Director of Aboriginal Health Western NSW LHD Darren Green Chief Executive Officer Walhallow Aboriginal Corporation
	Aboriginal community-led research Chair: Professor Tracey O’Brien AM Professor Jacinta Elston Indigenous Advisor Cancer Australia Mr Zarayn Knight Aboriginal Health Outcomes Lead Cancer Institute NSW Mr Anthony Carter Director, Aboriginal Strategy Engagement Cancer Institute NSW
5.00pm	Poster display and networking function
6.30pm	End of day 1

Time	Day 2
7.00am	Registration open
7.00am	Breakfast session
	Sponsor: University of Sydney	Sponsor: University of Sydney		Sponsors: Bellberry and University of Sydney
	Room: C3.3 Breakfast session 1 Digital health innovation: A Canadian perspective Facilitated by: Mr Mike Lovas Director, Design and Innovation Cancer Digital Intelligence, Princess Margaret Cancer Centre, UHN, Canada Mr John Sheedy Chief Information Officer Cancer Institute NSW	Room: C3.4/3.5 Breakfast session 2 Measuring the system through an equity lens Facilitated by: Associate Professor Abhijit Pal Staff Specialist Medical Oncologist South Western Sydney Local Health District Mr Rami Rahal Chief Executive Te Aho o Te Kahu New Zealand Mr Te Miri Rangi Chief Advisor Māori, Tākai Aronui Te Aho o Te Kahu New Zealand Dr Ru Kwedza Associate Director, Strategy, Quality, and System Performance, Cancer Institute NSW		Room: C3.6 Breakfast session 3 EMCRs - Engaging with consumers/patients/carers for impactful research outcomes Facilitated by: Professor Nikola Bowden Vanessa McGuigan HMRI Fellow in Ovarian Cancer Research University of Newcastle and Hunter Medical Research Institute and Lead NSW Regional Cancer Research Network Kathryn Leaney Cancer Voices NSW
9.00am	Session 5: Plenary session
	Personalised care within the system Chair:Professor Tracey O’Brien AM Room: Plenary Cockle Bay Room
9.00am	Opening address Ms Susan Pearce AM Secretary, NSW Health
9.10am	Plenary presentation Ms Nicole Turner Chief Executive Officer, Aboriginal Health and Medical Research Council of NSW
9.22am	Plenary presentation Mr Rami Rahal Chief Executive Te Aho o Te Kahu New Zealand Mr Te Miri Rangi Chief Advisor Māori, Tākai Aronui Te Aho o Te Kahu New Zealand
9.34am	Plenary presentation Professor Paul Harnett AM Director, The Crown Princess Mary Cancer Centre-Westmead Hospital Western Sydney Local Health District
9.46am	Plenary presentation Professor Bogda Koczwara AM Director, Australian Research Centre for Cancer Survivorship University of New South Wales
9.58am	Panel Q&A Hosted by: Professor Tracey O'Brien AM Ms Susan Pearce AM Secretary, NSW Health Ms Nicole Turner Chief Executive Officer, Aboriginal Health and Medical Research Council of NSW Mr Rami Rahal Chief Executive, Te Aho o Te Kahu New Zealand Mr Te Miri Rangi Chief Advisor Māori, Tākai Aronui Te Aho o Te Kahu New Zealand Professor Paul Harnett AM Director, The Crown Princess Mary Centre- Westmead Hospital Western Sydney Local Health District Professor Bogda Koczwara AM Director, Australian Research Centre for Cancer Survivorship University of New South Wales
10.30am	Morning tea Poster viewing
11.00am	Session 6: Day 2 morning concurrent
	Room: Plenary Cockle Bay Room Discovery to treatment: Accelerating the translation of research into clinical care Chair: Professor Nikola Bowden University of Newcastle Co-chair: Dr Nicola Meagher Daffodil Centre	Room: C3.3 Connecting across the system: Building integrated care models Chairs: Professor Reema Harrison Macquarie University Dr Ramya Walsan Macquarie University	Room: C3.4/C3.5 Next-generation cancer screening: Shaping the future of early detection Chair: Associate Professor Marianne Weber University of Sydney Co-chair: Mary Mitchelhill Cancer Institute NSW	Room: C3.6 Supporting better cancer care together Co-chair: Shelley Rushton Cancer Institute NSW Co-chair: Alexis Gazzard Cancer Institute NSW
11.00am	Professor Nikola Bowden University of Newcastle Drug repurposing for treatment resistant cancers: translation from the lab to clinical trials	Professor Reema Harrison Macquarie University Using patient reported data to support integrated care models	Dr Lesley Andrews South Eastern Sydney Local Health District Optimising breast screening in "high risk" women - which women, what modality and who pays	Ms Tayhla Ryder Canteen ‘Someone that didn't treat me like a child': Patient experiences in the Youth Cancer Service Dr Lukas Hofstaetter Carers NSW Supporting carers of people living with cancer: Evidence from the 2024 National Carer Survey Anne Caboche Western Sydney Local Health District Talking to me – In Language improvements to support culturally and linguistically diverse cancer patients
11.15am	Associate Professor Christine Chaffer Garvan Institute for Medical Research Bench-to-bedside: State-gating cancer via AR inhibition prevents chemotherapy resistance in triple-negative breast cancer	Associate Professor Merran Findlay University of New South Wales No longer optional: Embedding nutrition care in quality cancer systems	Professor Deborah Bateson AM University of Sydney Shaping the future in cancer screening: eliminating cervical cancer equitably
11.30am	Professor Aaron Sverdlov University of Newcastle New strategies to protect against anthracycline cardiotoxicity	Dr Vivek Bhadri Chris O'Brien Lifehouse Adolescent and young adult cancer – sealing the cracks through collaboration	Professor Rachael Morton NHMRC Clinical Trials Centre Economic evidence for a targeted melanoma screening program	Ms Jilly Pascoe OAM Life Force Cancer Foundation Emily Roy Health and Wellbeing Plus / Joblink Plus Enhancing psychosocial cancer support in regional NSW: Integrating the Life Force holistic recovery model Dr Alison Guo ACON Enhancing LGBTQ+ inclusion in colonoscopy services: Insights from a community-led study Ms Cindy Lyons and Mrs Louise Diviney Central Coast Local Health District Tell Her From Me: Connecting women through their stories
11.45am	Mr Oliver Liang Centenary Institute Exploring adoptive T Cell therapies in appendiceal cancer	Dr Youngeun Koo Liverpool Cancer Therapy Centre Quality of decision-making at oncology multidisciplinary team meetings: A structured observational study	Associate Professor Marianne Weber University of Sydney Future efficiencies in lung cancer screening: How innovations in early detection could impact Australia’s newest screening program
12.00pm	Mr Ezekiel Otaegui-Campos University of New South Wales TLR4 regulates chronic inflammation during Helicobacter pylori infection to promote gastric carcinogenesis	Professor John Moore The Kinghorn Cancer Centre Collaboration for a cure: Establishing institutional readiness for solid tumour and autoimmune-directed cellular therapies	Miss Daniella Edward Flinders University Harnessing real-world data to inform cancer prevention and care strategies	Mrs Chelsea Pirodon Lung Foundation Australia First Nations youth: A co-designed vaping project - a collaboration success story
12.10pm	Dr Sayantani Chatterjee Macquarie University Protein mannosylation: Tumour-associated glycoepitopes across human cancers	Dr Christine O’Neill John Hunter Hospital and University of Newcastle Decision aid for low-risk thyroid cancer: A mixed-methods development process partnering with patients and clinicians	Dr Joachim Worthington The Daffodil Centre The future of cost-effective liver cancer screening and surveillance in Australia	Dr Rugmini Venkatraman Pink Sari Inc CanInfo & Care – A project towards achieving equitable cancer outcomes for South-Asian families
12.20pm	Dr Hilary Byrne GenesisCare Computed apparent diffusion coefficient in prostate cancer for treatment response monitoring: An MR-Linac feasibility study	Dr Rachel Brookes South Western Sydney Local Health District Leveraging real-world data: A digital dashboard to improve evidence-based radiotherapy for bone metastases	Dr Amin Hassan-Zadeh Macquarie University CTC profiling via microchip for early detection and treatment monitoring in breast cancer	Ms Gretel Knight Multicultural Health Services Hunter New England Local Health District Breaking the cycle: A culturally tailored smoking cessation program empowering the Ezidi community in Armidale
12.30pm	Lunch Poster viewing
1.30pm	Session 7: Day 2 afternoon concurrent
	Room: Plenary Cockle Bay Room Breakthroughs in oncology Chair: Professor Georgina Long AO Melanoma Institute Australia University of Sydney Co-Chair: Associate Professor Jenny Lee Macquarie University	Room: C3.3 The data revolution: Leveraging real-world data for better cancer outcomes Chair: Professor Geoff Delaney Maridulu Budyari Gumal (SPHERE) Co- Chair: Mr Richard Walton Cancer Institute NSW	Room: C3.4/C3.5 Equity unbound: Reimagining cancer care Chair: Dr Fiona Abell Hunter New England Local Health District Co-chair: Ms Maria Mury Cancer Institute NSW	Room: C3.6 The power of partnership: Co-creation with community Chair: Ms Elisabeth Kochman Cancer Voices NSW Co-Chair: Ms Sheetal Challam Cancer Institute NSW
1.30pm	Professor Vincent Lam Macquarie University Minimally versus maximally invasive cancer surgery, and use of the robot	Professor Geoff Delaney Maridulu Budyari Gumal (SPHERE) Watch out - big data is coming to a clinic near you	Mrs Melissa Mudie and Ms Molly Sinclair Southern NSW Local Health District Realigning SNSWLHD cancer services to deliver high quality care closer to home Mrs Felicity Bates Mid North Coast Local Health District Existential distress in rural palliative care, including cancer patients: Associations between pain, medications, and demographics	Mr Peter Bligh National Aboriginal Community Controlled Health Organisation
1.45pm	Professor Nick Pavlakis University of Sydney NSCLC: Clinical application of ctDNA and therapeutic breakthroughs	Mr Richard Walton Cancer Institute NSW New approaches to analyse and understand cancer treatment pathways	Miss Estelle Blowes Western NSW Local Health District Cervical screening during pregnancy for midwives: Integrating cervical cancer prevention into perinatal care	Mr Scott Walsberger ACON Realising a shared vision for LGBTQ+ cancer equity through empowering communities and amplifying voices
2.00pm	Professor Georgina Long AO Melanoma Institute Australia University of Sydney Melanoma: The platform reshaping cancer treatment	Dr Georgina Kennedy Maridulu Budyari Gumal (SPHERE) Real-world data insights to bridge research and care	Ms Ro Stirling-Kelly Agency for Clinical Innovation Mr Paul Morris Durri Aboriginal Corporation Medical Service Finding your way: A co-designed shared decision making approach to improve Aboriginal bowel cancer outcomes	Associate Professor Abhijit Pal South West Sydney Local Health District Sharing institutional power with diverse communities to enable best practice in cancer care – strategies, lessons and methods
2.15pm	Professor Lorraine Chantrill Illawarra Shoalhaven Local Health District Bringing treatment forward in GI cancer – the benefits of neoadjuvant treatments in GI cancers	Dr Candice Donnelly University of Sydney Beyond the dashboard: Are cancer services ready for a digital analytics future?	Mr Matthew Fuller Western NSW Local Health District Simulation-free radiation therapy to improve equitable access for palliative cancer patients in Western NSW Ms Danielle Parkes Western NSW Local Health District Improving rural cancer care through automated patient-reported measures: Implementation of a pre-consultation survey system	Ms Dana Mouwad NSW Health Statewide Health Literacy Hub Designing for diversity - cancer communication and community partnerships - a health literacy approach
2.30pm	Miss Courtney Leslie GenesisCare Treatment of cardiac metastases with magnetic resonance-guided radiation therapy	Mr David Goldsbury The Daffodil Centre Health system costs and systemic treatment by disease stage for people diagnosed with melanoma 2005-2019	Anna Hartley Cancer Institute NSW Decentralised clinical trials in remote, rural and regional communities.	Miss Emily Jenkinson Cancer Council NSW From data to policy: Preventive health lessons from generation vape
2.40pm	Dr Samantha Wade University of Wollongong Evaluation of 5-FU, irinotecan, and oxaliplatin implants for pancreatic cancer in mouse andpig models	Dr Amita Sen GenesisCare MRI guided stereotactic prostate radiotherapy: Assessment of urethral dose and urinary toxicity	Sarah Elliott Illawarra Shoalhaven Local Health District Creating a cancer centre for all our patients	Rod Hammond Western NSW Local Health District Giving voice to experience: Reducing barriers to radiation therapy for Aboriginal men in Western NSW
2.50pm	Ms Fahmida Islam Monash University Can dual specific CAR NK cells enhance solid tumour targeting?	Mr Philip Ly The Daffodil Centre Towards risk-based prostate cancer early detection: Integrating genomic information in risk prediction	Ms Natalie Smith University of Sydney Novel Immune Monitoring Strategy to enable equity in cancer prognosis for individuals from remote settings	Associate Professor Ursula Sansom-Daly University of New South Wales What is the value of online, group-based psychosocial support for adolescent/young adult cancer survivors?
3.00pm	Afternoon tea Poster viewing
3.30pm	Session 8: Panel discussion
	The next horizon: Navigating cancer control amid emerging megatrends Chair: Professor Tracey O'Brien AM Room: Plenary Cockle Bay Room
3.40pm	Panel discussion and Q&A Panel members: Professor Dorothy Keefe PSM Chief Executive Officer Cancer Australia Ms Nyan Thit Tieu Founder and Chair Sisters Cancer Support Group Dr Kerry Chant AO PSM Chief Health Officer Deputy Secretary Population and Public Health NSW Ministry of Health Dr Teresa Anderson AM Chief Executive NSW Health Single Digital Patient Record Implementation Authority Nadia Levin CEO and Managing Director Research Australia
4.20pm	Awards
4.30pm	Closing remarks Professor Tracey O’Brien AM NSW Chief Cancer Officer and Chief Executive Officer, Cancer Institute NSW
	End of conference

International speakers announced

Mr Mike Lovas
Mr Rami Rahal
Mr Te Miri Rangi

Mr Mike Lovas
Director of Design and Innovation at Cancer Digital Intelligence, University Health Network, Canada

Mike is the Director of Design and Innovation at Cancer Digital Intelligence, the innovation program at the Princess Margaret Cancer Centre, University Health Network.

He is also an AMS-Fitzgerald Fellow in AI and Human-Centred Leadership at the University of Toronto. With over 15 years of experience, Mike combines expertise in service design, biomedical engineering, healthcare innovation consulting, and technology entrepreneurship.

A recent personal experience with cancer has led Mike to rethink the patient journey, focusing his efforts on improving care beyond the cancer centre, where most symptoms arise but resources are limited and poorly coordinated.

In addition to his professional work, Mike also mentors graduate students and lectures at the University of Toronto’s Master of Health Informatics and iSchool UX programs, as well as OCAD (Ontario College of Art & Design) University’s Design for Health program.

Mr Rami Rahal
Chief Executive of Te Aho o Te Kahu, New Zealand’s Cancer Control Agency

Rami was appointed Tumuaki (Chief Executive) in July 2023, bringing with him over thirty years of health system leadership experience and dedication to improving outcomes for people affected by cancer, particularly indigenous communities.

For the past 12 years, Rami has held several senior leadership roles at the Canadian Partnership Against Cancer (Canada’s national cancer agency). There, he led the implementation of major cancer research projects including Canada’s largest population cohort study. He also played a key role in advancing indigenous data and research and led the design and implementation of cancer system quality measurement and improvement initiatives. Rami was also responsible for international partner engagement where he developed strong international networks, including clinicians and cancer care leaders across Aotearoa.

Prior to his career at the Canadian Partnership Against Cancer Rami led a healthcare management consultancy firm, providing policy and planning decision support to cancer agencies and other health care organisations across Canada. Rami holds a Master of Business Administration, Health Services Management, from McMaster University, Hamilton, Canada. He also holds a Bachelor of Science (Honours) in Molecular Biology and Genetics from the University of Toronto, Canada.

Mr Te Miri Rangi
Chief Advisor Māori, Tākai Aronui, Te Aho o Te Kahu

Te Miri (Ngāti Tūwharetoa, Te Arawa, Ngāti Raukawa) provides strategic leadership to the agency so that Te Tiriti o Waitangi and the aspirations of whānau Māori are at the heart of cancer care in Aotearoa. His role involves collaborating with iwi, Māori health leaders, and clinical partners to drive health equity and improve outcomes for tangata whenua. His expertise and cultural insights are supporting the development of Māori capability across the agency and help shape approaches that will deliver real, meaningful change in cancer prevention and treatment for all people and whānau across the motu.

Before joining the agency, Te Miri held senior roles at ACC, Te Hiringa Hauora Health Promotion Agency, Skills Active Aotearoa, and Te Papa Tākaro o Te Arawa where he embedded kaupapa Māori approaches into quality programmes and projects that support Māori to realise their potential in health.

Get ready to hear from leading experts in cancer control.

Learn more about our exciting lineup of preeminent local, national and international speakers.

Sponsorship

Sponsoring the NSW Cancer Summit 2025 provides a unique opportunity to engage with a diverse audience of world-leading cancer specialists and researchers as well as consumers, community leaders and industry stakeholders.

Choose from a variety of packages aligned with your brand and philanthropic goals or collaborate with us to create a tailored package.

Your sponsorship will deliver tangible benefits:

Enhanced brand visibility: showcase your brand to more than 500 influential attendees through the event, including prime placement on the Summit website, social media, and printed materials.
Strategic networking: connect with key decision-makers and industry leaders, fostering valuable relationships.
Thought leadership: gain exclusive insights into groundbreaking research and emerging trends in cancer care.
Positive impact: align your brand with a cause that matters, demonstrating your commitment to improving cancer outcomes.
Tailored partnerships: collaborate with us to create a customised sponsorship package that aligns with your specific goals and budget.

For all sponsorship enquiries please contact our events team via cinsw-events@health.nsw.gov.au.